Universal pharmacare in Canada: A prescription for equity in healthcare
Authors: Mohammad Hajizadeh and Sterling Edmonds
Despite progressive universal drug coverage and pharmaceutical policies found in other countries, Canada remains the only developed nation with a publicly funded healthcare system that does not include universal coverage for prescription drugs. In the absence of a national pharmacare plan, a province may choose to cover a specific sub-population for certain drugs. Although different provinces have individually attempted to extend coverage to certain subpopulations within their jurisdictions, out-of-pocket expenses on drugs and pharmaceutical products (OPEDP) accounts for a large proportion of out-of-pocket health expenses (OPHE) that are catastrophic in nature. Pharmaceutical drug coverage is a major source of public scrutiny among politicians and policy-makers in Canada. In this editorial, we focus on social inequalities in the burden of OPEDP in Canada. Prescription drugs are inconsistently covered under patchworks of public insurance coverage, and this inconsistency represents a major source of inequity of healthcare financing. Residents of certain provinces, rural households and Canadians from poorer households are more likely to be affected by this inequity and suffer disproportionately higher proportions of catastrophic out-of-pocket expenses on drugs and pharmaceutical products (COPEDP). Universal pharmacare would reduce COPEDP and promote a more equitable healthcare system in Canada.
Please note that abstracts only appear in the language of the publication and might not have a translation.
|Author||Mohammad Hajizadeh and Sterling Edmonds|
|Title||Universal pharmacare in Canada: A prescription for equity in healthcare|
|Journal Name||International Journal of Health Policy and Management|
- Mohammad Hajizadeh
- Mohammad Hajizadeh and Sterling Edmonds
- Universal pharmacare in Canada: A prescription for equity in healthcare
- International Journal of Health Policy and Management
Mohammad Hajizadeh, Arnold Mitnitski, and Kenneth Rockwood (2016).
Socioeconomic gradient in health in Canada: Is the gap widening or narrowing?
Health Policy , 1040-1050
Mohammad Hajizadeh, Min Hu, Yukiko Asada, and Amy Bombay (2021).
Psychological distress and suicidal behaviours in Indigenous and non-Indigenous s living off-reserve in Canada: What explains the differences?
CMAJ Open , 215-223
Kurt Willis and Mohammad Hajizadeh (2020).
Socioeconomic inequalities in gastric cancer incidence in Canada: 1992–2010
Acta Oncologica , 1333 – 1337
Mohammad Hajizadeh, Grace M. Johnston, and Daria Manos (2020).
Socio-economic inequalities in lung cancer incidence in Canada, 1992–2010: Results from the Canadian Cancer Registry
Public Health , 189-195
Marie Charles and Mohammad Hajizadeh (2020).
Trends in socioeconomic inequalities in the incidence of cutaneous melanoma in Canada from 1992 to 2010
Journal of Public Health
Carol Morriscey and Mohammad Hajizadeh (2020).
Income and education inequalities in cervical cancer incidence in Canada, 1992-2010
Journal of Public Health
Mohammad Hajizadeh, M. Karen Campbell, and Sisira Sarma (2014).
Socioeconomic inequalities in adult obesity risk in Canada: Trends and decomposition analyses
European Journal of Health Economics , 203-221